Human trial suggests CRISPR could be a viable cancer treatment
Scientists from the University of Pennsylvania just published the results of the first U.S. trial of CRISPR-edited cells in cancer patients — and they’re very encouraging. In April 2019, UPenn confirmed that a team of its researchers had officially begun testing CRISPR-edited cells in humans.
Continue Reading https://futurism.com
Join the Discussion